CO5540278A2 - Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion - Google Patents
Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacionInfo
- Publication number
- CO5540278A2 CO5540278A2 CO03111139A CO03111139A CO5540278A2 CO 5540278 A2 CO5540278 A2 CO 5540278A2 CO 03111139 A CO03111139 A CO 03111139A CO 03111139 A CO03111139 A CO 03111139A CO 5540278 A2 CO5540278 A2 CO 5540278A2
- Authority
- CO
- Colombia
- Prior art keywords
- agent
- alkaline
- formulation according
- formulation
- meglumine
- Prior art date
Links
- 239000000796 flavoring agent Substances 0.000 title abstract 2
- 235000019634 flavors Nutrition 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 5
- 238000009472 formulation Methods 0.000 abstract 4
- 229920000642 polymer Polymers 0.000 abstract 4
- 239000003463 adsorbent Substances 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 2
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 abstract 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract 2
- 229910052782 aluminium Inorganic materials 0.000 abstract 2
- 229960003194 meglumine Drugs 0.000 abstract 2
- 125000005395 methacrylic acid group Chemical group 0.000 abstract 2
- 230000007935 neutral effect Effects 0.000 abstract 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 abstract 2
- 229910052708 sodium Inorganic materials 0.000 abstract 2
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 abstract 1
- 239000001856 Ethyl cellulose Substances 0.000 abstract 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000008135 aqueous vehicle Substances 0.000 abstract 1
- 229920006317 cationic polymer Polymers 0.000 abstract 1
- 229920001249 ethyl cellulose Polymers 0.000 abstract 1
- 235000019325 ethyl cellulose Nutrition 0.000 abstract 1
- 159000000011 group IA salts Chemical class 0.000 abstract 1
- 235000018977 lysine Nutrition 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000391 magnesium silicate Substances 0.000 abstract 1
- 229910052919 magnesium silicate Inorganic materials 0.000 abstract 1
- 235000019792 magnesium silicate Nutrition 0.000 abstract 1
- 230000000873 masking effect Effects 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 235000011181 potassium carbonates Nutrition 0.000 abstract 1
- 239000001508 potassium citrate Substances 0.000 abstract 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical class [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 abstract 1
- 235000011082 potassium citrates Nutrition 0.000 abstract 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 abstract 1
- 235000011182 sodium carbonates Nutrition 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- 235000011083 sodium citrates Nutrition 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000000454 talc Substances 0.000 abstract 1
- 229910052623 talc Inorganic materials 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0108157A FR2826274B1 (fr) | 2001-06-21 | 2001-06-21 | Formulation pharmaceutique au gout masque et son procede de preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5540278A2 true CO5540278A2 (es) | 2005-07-29 |
Family
ID=8864587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO03111139A CO5540278A2 (es) | 2001-06-21 | 2003-12-19 | Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion |
Country Status (41)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7384921B2 (en) * | 2004-02-20 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | Polymorphic forms of 6-11 bicyclic ketolide derivatives |
| GB2419094A (en) * | 2004-10-12 | 2006-04-19 | Sandoz Ag | Pharmaceutical composition of unpleasnt tasing active substances |
| FR2882522B1 (fr) * | 2005-02-25 | 2007-04-13 | Aventis Pharma Sa | Composition pharmaceutique solide comprenant de la telithromycine |
| US7384922B2 (en) * | 2005-05-04 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | 6-11 bridged oxime erythromycin derivatives |
| US20060264386A1 (en) * | 2005-05-17 | 2006-11-23 | Rongqi Sun | Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof |
| US20090011007A1 (en) * | 2006-02-03 | 2009-01-08 | Evonik Roehm Gmbh | Pharmaceutical Compositions Containing Mixtures of Polymers and Active Agents Poorly Soluble in Water |
| US20100226979A1 (en) * | 2006-03-21 | 2010-09-09 | Jubilant Organosys Limited | Taste Masked Phamaceutical Composition for Oral Solid Dosage form and Process for Preparing the Same Using Magnesium Aluminium Silicate |
| US20080181932A1 (en) * | 2007-01-30 | 2008-07-31 | Drugtech Corporation | Compositions for oral delivery of pharmaceuticals |
| KR100935893B1 (ko) * | 2007-09-11 | 2010-01-07 | 국방과학연구소 | 1,1'-다이메틸-5,5’-바이테트라졸의 합성방법 |
| EP2214484A4 (en) | 2007-10-25 | 2013-01-02 | Cempra Pharmaceuticals Inc | PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS |
| BRPI0922382B1 (pt) | 2008-12-16 | 2019-06-18 | Carlsberg A/S | Material de polímero à base de celulose, recipiente para armazenamento de líquidos, material para armazenamento de alimentos e método para preparar o referido material |
| NZ700182A (en) | 2012-03-27 | 2017-02-24 | Cempra Pharmaceuticals Inc | Parenteral formulations for administering macrolide antibiotics |
| DE102012014848A1 (de) * | 2012-07-27 | 2012-10-31 | Heilerde-Gesellschaft Luvos Just GmbH & Co. KG | Heilerde-Zubereitung |
| SG11201700827RA (en) * | 2014-08-05 | 2017-03-30 | Cempra Pharmaceuticals Inc | Powder oral suspension formulations of antibacterial agents |
| US10982177B2 (en) | 2017-09-18 | 2021-04-20 | The Clorox Company | Cleaning wipes with particular lotion retention and efficacy characteristics |
| CN114209661B (zh) * | 2022-02-21 | 2022-04-29 | 北京罗诺强施医药技术研发中心有限公司 | 呈细粒形式的固体药物组合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2930409A1 (de) * | 1979-07-26 | 1981-02-12 | Bayer Ag | Spruehtrocknung von mikrokapseldispersionen |
| JPS63150220A (ja) * | 1986-12-15 | 1988-06-22 | Dainippon Pharmaceut Co Ltd | 経口用固形製剤の製造方法 |
| US4808411A (en) * | 1987-06-05 | 1989-02-28 | Abbott Laboratories | Antibiotic-polymer compositions |
| US5084278A (en) * | 1989-06-02 | 1992-01-28 | Nortec Development Associates, Inc. | Taste-masked pharmaceutical compositions |
| ZA945944B (en) * | 1993-08-13 | 1996-02-08 | Eurand America Inc | Procedure for encapsulating nsaids |
| AUPN969796A0 (en) * | 1996-05-07 | 1996-05-30 | F.H. Faulding & Co. Limited | Taste masked liquid suspensions |
| JP2001518490A (ja) * | 1997-10-03 | 2001-10-16 | エラン コーポレーシヨン ピーエルシー | 味遮蔽された製剤 |
| IN191239B (https=) * | 1999-06-11 | 2003-10-11 | Ranbaxy Lab Ltd | |
| US6555569B2 (en) * | 2000-03-07 | 2003-04-29 | Pfizer Inc. | Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection |
| JP4162992B2 (ja) * | 2000-08-22 | 2008-10-08 | バジリア ファルマスーチカ アーゲー | 抗菌活性を有する新規マクロライド |
-
2001
- 2001-06-21 FR FR0108157A patent/FR2826274B1/fr not_active Expired - Fee Related
-
2002
- 2002-05-08 TW TW091109613A patent/TWI228049B/zh not_active IP Right Cessation
- 2002-05-09 JO JO200241A patent/JO2325B1/en active
- 2002-06-11 GT GT200200115A patent/GT200200115A/es unknown
- 2002-06-11 GT GT200200115AK patent/GT200200115AA/es unknown
- 2002-06-17 MY MYPI20022250A patent/MY134340A/en unknown
- 2002-06-18 PE PE2002000522A patent/PE20030201A1/es not_active Application Discontinuation
- 2002-06-18 UY UY27341A patent/UY27341A1/es not_active Application Discontinuation
- 2002-06-19 SV SV2002001098A patent/SV2003001098A/es not_active Application Discontinuation
- 2002-06-19 AR ARP020102300A patent/AR036096A1/es not_active Application Discontinuation
- 2002-06-19 PA PA20028548301A patent/PA8548301A1/es unknown
- 2002-06-21 CA CA2452239A patent/CA2452239C/fr not_active Expired - Fee Related
- 2002-06-21 IL IL15940402A patent/IL159404A0/xx active IP Right Grant
- 2002-06-21 AT AT02764922T patent/ATE290366T1/de active
- 2002-06-21 CN CNB028121465A patent/CN1239149C/zh not_active Expired - Fee Related
- 2002-06-21 MX MXPA03011756A patent/MXPA03011756A/es active IP Right Grant
- 2002-06-21 BR BRPI0208998A patent/BRPI0208998A2/pt not_active IP Right Cessation
- 2002-06-21 TN TNPCT/FR2002/002158A patent/TNSN03141A1/fr unknown
- 2002-06-21 NZ NZ530042A patent/NZ530042A/en not_active IP Right Cessation
- 2002-06-21 HR HR20031067A patent/HRP20031067B1/xx not_active IP Right Cessation
- 2002-06-21 EP EP02764922A patent/EP1401397B1/fr not_active Expired - Lifetime
- 2002-06-21 AP APAP/P/2003/002927A patent/AP1595A/en active
- 2002-06-21 PT PT02764922T patent/PT1401397E/pt unknown
- 2002-06-21 PL PL366803A patent/PL202090B1/pl unknown
- 2002-06-21 WO PCT/FR2002/002158 patent/WO2003000225A2/fr not_active Ceased
- 2002-06-21 HU HU0400799A patent/HUP0400799A3/hu unknown
- 2002-06-21 SK SK1592-2003A patent/SK285865B6/sk not_active IP Right Cessation
- 2002-06-21 ES ES02764922T patent/ES2236574T3/es not_active Expired - Lifetime
- 2002-06-21 JP JP2003506872A patent/JP4880871B2/ja not_active Expired - Fee Related
- 2002-06-21 CZ CZ20033441A patent/CZ299947B6/cs not_active IP Right Cessation
- 2002-06-21 DE DE60203178T patent/DE60203178T2/de not_active Expired - Lifetime
- 2002-06-21 AU AU2002329311A patent/AU2002329311B2/en not_active Ceased
- 2002-06-21 UA UA2004010425A patent/UA77960C2/uk unknown
- 2002-06-21 OA OA1200300340A patent/OA12635A/fr unknown
- 2002-06-21 EA EA200400061A patent/EA006016B1/ru not_active IP Right Cessation
-
2003
- 2003-12-05 ZA ZA2003/09479A patent/ZA200309479B/en unknown
- 2003-12-12 US US10/735,538 patent/US7138138B2/en not_active Expired - Lifetime
- 2003-12-15 NO NO20035581A patent/NO332258B1/no not_active IP Right Cessation
- 2003-12-16 BG BG108458A patent/BG66314B1/bg unknown
- 2003-12-16 MA MA27445A patent/MA27042A1/fr unknown
- 2003-12-16 IL IL159404A patent/IL159404A/en not_active IP Right Cessation
- 2003-12-18 EC EC2003004915A patent/ECSP034915A/es unknown
- 2003-12-19 CO CO03111139A patent/CO5540278A2/es active IP Right Grant
-
2006
- 2006-09-20 US US11/533,573 patent/US20070014857A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5540278A2 (es) | Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion | |
| ES2542728T3 (es) | Composiciones farmacéuticas que tienen la biodisponibilidad deseable | |
| CO6150127A2 (es) | Formulaciones de flibanserina y metodo para fabricarlas | |
| RU2012101818A (ru) | Наноструктурированное основание силденафила, его фармацевтически приемлемые соли и со-кристаллы, их композиции, способ их получения и содержащие их фармацевтические композиции | |
| AR027179A1 (es) | Formulas farmaceuticas liquidas de sabor enmascarado | |
| PA8509001A1 (es) | Forma de dosificacion de farmacos accionada por un hidrogel | |
| JP2008501802A5 (https=) | ||
| AR057422A1 (es) | Uan composicion farmaceutica de liberacion modificada, proceso de preparacion de dicha composicion y metodo para emplear la misma | |
| RU2003132426A (ru) | Фармацевтический раствор арипипразола для орального применения | |
| KR20100095443A (ko) | 광역학 치료 및 진단을 위한 고체 형태로서 ５―아미노레불린산 및 그것의 유도체의 용도 | |
| ATE429416T1 (de) | Cyanophenoxy-carbonsäuren und zusammensetzungen für die freisetzung aktiver substanzen | |
| JP2005523313A (ja) | 目の酒さ及び酒さ性ざ瘡の同時治療方法 | |
| RU2011135417A (ru) | Галеновы препараты органических соединений | |
| ES2311442T1 (es) | Dosis en forma oral. | |
| ES2224917T1 (es) | Composiciones farmaceuticas de agente fibrinolitico. | |
| AR054238A1 (es) | Composicion farmaceutica que contiene una biguanida y un derivado de tiazolidindiona | |
| CN109414423A (zh) | 包含丙戊酸的延迟释放药物制剂和其用途 | |
| ES2584534A1 (es) | Formulación tópica oftálmica de bosentan | |
| RU2008151945A (ru) | Лекарственные формы с пульсирующим высвобождением и фармацевтические композиции фенилэфрина | |
| PE20051163A1 (es) | Formas de dosificacion oral de acido n-(2-(2-ftalimido-etoxi)-acetil)-l-alanil-d-glutamico (lk 423) | |
| KR100366373B1 (ko) | 가용화된 세트랄린 조성물 | |
| JP2006524190A5 (https=) | ||
| WO2021244481A1 (en) | Compositions and methods for treating a sars-cov-2 infection | |
| JP5232641B2 (ja) | 新規なアセチルサリチル酸製剤 | |
| ES2310550T3 (es) | Preparacion liquida acuosa de pranoprofeno. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Application granted |